2013 Media Partners
The Drug Channels blog delivers timely analysis and provocative opinions on pharmaceutical economics and the drug distribution system. It is written by Adam J. Fein, Ph.D., President of Pembroke Consulting, Inc. and CEO of Drug Channels Institute. He is one of the country's foremost experts on pharmaceutical economics and channel strategy.
Drug Discount Monitor
Staying on top of the 340B program is now more important than ever. The Drug Discount Monitor covers the latest developments on Capitol Hill, the regulatory agencies and the broader world of 340B. The Monitor’s Washington, D.C.-based staff has the inside scoop on 340B, a program that includes more than 20,000 covered entities and sites, thousands of pharmacies and over 900 pharmaceutical manufacturers. Our online news service and breaking e-news alerts are read by thousands of 340B stakeholders, including health care providers, government, and industry. You can count on the Monitor as your guide to the 340B program.
In addition, advertising in the Monitor is a cost-effective way to reach out to key decision-makers affected by the 340B program. To learn more about subscription or advertising opportunities, go to www.drugdiscountmonitor.com or contact Brian Johnston at firstname.lastname@example.org or (202) 552-5864. The Monitor is published by Safety Net Hospitals for Pharmaceutical Access (SNHPA) and is complimentary for SNHPA member hospitals and discounted to SNHPA corporate partners.
HealthEconomics.Com is the world’s most comprehensive and credible website for resources and jobs in healthcare value and market access. It is the #1 Google website in health economics, outcomes research, market access, pricing, and reimbursement resources, conferences, and jobs. A trusted resource, HealthEconomics.Com contains the hottest news, jobs, policy updates, professional development, and education resources, and offers unparalleled advertising opportunities.http://www.healtheconomics.com